Sign in
Taking peopleNo phase

Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study

Key facts

Who runs it
Bio Refine Ltd.
Where
Hungary, Israel, Poland, and Serbia8 sites in 4 countriesChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
15 people, planned
Started
3 Jun 2024
Expected to end
Apr 2028
Type of study
Interventional
Treatments tested
  • Coriofix System
Record updated
2 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Local heart team has determined that mitral valve surgery will not be offered as a treatment option
  • Symptomatic secondary mitral regurgitation (3+ or 4+)
  • Adequately treated in compliance with optimal guideline-directed medical therapy for heart failure for at least 90 days
  • NYHA functional class II, III or ambulatory IV
  • LVEF ≥30%
  • Written informed consent has been obtained

Who cannot take part

  • CABG, PCI or TAVR within the prior 90 days
  • COPD requiring continuous home oxygen therapy or chronic outpatient oral steroid use
  • CVA or TIA within prior 180 days
  • Prior mitral valve leaflet surgery or any currently implanted prosthetic mitral valve, or any prior transcatheter mitral valve procedure
  • Currently participating in an investigational drug or another device study that has not reached its primary endpoint
  • Untreated clinically significant coronary artery disease requiring revascularization
  • Aortic or tricuspid valve disease requiring surgery or transcatheter intervention or severe tricuspid regurgitation
  • Any history of ventricular arrythmia
  • Life expectancy <12 months due to non-cardiac conditions
  • Hypotension
  • Patients implanted with any kind of CIED
  • TEE is contraindicated or high risk
  • Pregnant or planning pregnancy within next 12 months

This trial has no sites in United States.

It has sites in 4 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the safety and feasibility of the Bio Refine Coriofix System and determine if it might help in treatment of functional mitral regurgitation.

Read full original descriptionShow less

The study will include patients with symptomatic secondary mitral regurgitation in whom mitral surgery cannot and/or will not be offered as a treatment option (the risk is prohibitive).

Potential patients will be screened to confirm that all inclusion/exclusion criteria are met, with final eligibility confirmation on day of procedure.

All enrolled subjects who went through the procedure will be followed during the procedure to hospital discharge.

Additional follow up time points are scheduled at 30 days, 6 months and 12 months post procedure.

The group in the trial

  • Coriofix treatmentTreatment being tested

    Treatment: Coriofix System

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
2 October 2026